ArticleFrontiers in immunology2025

Developing transcriptomic biomarkers for TAVO412 utilizing next generation sequencing analyses of preclinical tumor models.

Ying Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.